Back

Initial experience with a virtual atrial fibrillation clinic after pulmonary vein isolation

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: eCardiology 3 Remote Patient Monitoring and Telehealth EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Jippe Balt

St Antonius Hospital, Nieuwegein (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Genetic, sociodemographic, lifestyle, and clinical risk factors of heart failure aggravation events: data from the UK Biobank
Doctor T. Hwang (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Spatiotemporal stability of digital twin-guided atrial fibrillation dominant frequency sites and the clinical outcome of catheter ablation
Doctor T. Hwang (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Artificial Intelligence-based Electrocardiogram prediction for duration of Atrial Fibrillation
Doctor Y. Park (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Predicting left atrial appendage thrombus in patients with persistent atrial fibrillation or flutter and no oral anticoagulation using machine-learning models.
Doctor B. Musielak (Nowa Sol, PL)
Abstract Slides Video
Presentation thumbnail
Clinical validation of an artificial intelligence algorithm offering automated corrected QT-interval measurements from a single lead electrocardiogram
Mr D. Mannhart (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
eCardiology 3

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
A virtual atrial fibrillation clinic after pulmonary vein isolation: lessons learned from 1000 patient-years.
thumbnail
Congress Presentation
Effectiveness of photoplethysmography-based rhythm monitoring after atrial fibrillation ablation using a smartphone application
thumbnail
Congress Presentation
Smartphone application-based heart rhythm management around cardioversion in patients with presumed persistent atrial fibrillation: feasibility substudy of TeleConvert-AF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources